MDCG 2024-10: Clinical Evaluation Guidelines for Orphan Medical Devices
MDCG 2024-10: Clinical Evaluation Guidelines for Orphan Medical Devices
Regulatory Affairs Medical Devices
Thursday, 27 June 2024
Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager IVD
Share
\
\
X (Twitter) 
\
\
LinkedIn 
\
\
WhatsApp 
\
\
Copy link 
\
\
Mail
On June 25th, 2024, the Medical Device Coordination Group (MDCG) released a new guidance on the clinical evaluation of orphan medical devices (MDCG 2024-10).
Play
Clinical Evaluation Guidelines for Orphan Medical Devices (MDCG 2024-10) | QbD Group
AI-generated audio
2:06
MDCG 2024-10 Clinical evaluation of orphan medical devices
This document provides guidance to manufacturers and notified bodies on the clinical evaluation pursuant to the Regulation (EU) 2017/745 on medical devices (MDR) of medical devices and accessories for medical devices that qualify as ‘orphan devices’ (OD) and medical devices and accessories for medical devices that have an orphan indication, within the meaning of this guidance.
This guidance is relevant to devices across all risk classes as per the classification rules defined in the MDR. This guidance gives particular attention to the clinical evaluation and investigation requirements stated in MDR Chapter VI and Annex XIV for these devices.
What does this mean to you?
- MDCG 2022-13 Revision 1 can be used as a reference to see how Notified Bodies are designated.
- MDCG 2022-04 Revision 2 is of interest if you have medical devices that have a notified body certificate under the directive and that is making use of the transitional provisions captured in Article 120 of the MDR. This guidance addresses how notified bodies should oversee legacy medical devices certified under the former Medical Devices Directive or Active Implantable Medical Devices Directive.
- MDCG 2024-1-5 DSVG 05 is of specific interest for manufacturers of Urogynaecological Surgical Mesh Implants used for Pelvic Organ Prolapse repair and Stress Urinary Incontinence to harmonise their vigilance reporting.
- MDCG 2024-10 is relevant to medical devices and accessories for medical devices that qualify as orphan devices and medical devices and accessories for medical devices that have an orphan indication.
Get in touch with our experts
Should you want to discuss this more in-depth with one of our consultants, please do not hesitate to contact us.
Discover more expert content
Previous
Regulatory Affairs
29 Oct 2024
First Revision of MDCG 2021-25 Released
Application of MDR requirements to “legacy devices” and to devices placed on the market prior to...
Regulatory Affairs
10 Jan 2025
New MDCG 2020-16 Revision 3 Guidance Documents Released
MDCG 2020-16 Revision 3: Guidance on classification Rules for in vitro Diagnostic Medical Devices...
Regulatory Affairs
14 Oct 2024
MDCG 2024-11 released
Regulatory Affairs
9 Jul 2024
MDCG: First Revision on the Guidance on Standardisation for Medical Devices
MDCG 2021-05 Revision 1: Guidance on standardization for medical devices The scope of this...
Regulatory Affairs
14 Oct 2024
MDCG 2024-12 released
It includes detailed sections on corrections, root cause analysis, corrective and preventive...
Regulatory Affairs
29 Oct 2024
First Revision of MDCG 2021-25 Released
Application of MDR requirements to “legacy devices” and to devices placed on the market prior to...
Regulatory Affairs
10 Jan 2025
New MDCG 2020-16 Revision 3 Guidance Documents Released
MDCG 2020-16 Revision 3: Guidance on classification Rules for in vitro Diagnostic Medical Devices...
Regulatory Affairs
14 Oct 2024
MDCG 2024-11 released
Regulatory Affairs
9 Jul 2024
MDCG: First Revision on the Guidance on Standardisation for Medical Devices
MDCG 2021-05 Revision 1: Guidance on standardization for medical devices The scope of this...
Regulatory Affairs
14 Oct 2024
MDCG 2024-12 released
It includes detailed sections on corrections, root cause analysis, corrective and preventive...
Regulatory Affairs
29 Oct 2024
First Revision of MDCG 2021-25 Released
Application of MDR requirements to “legacy devices” and to devices placed on the market prior to...
Regulatory Affairs
10 Jan 2025
New MDCG 2020-16 Revision 3 Guidance Documents Released
MDCG 2020-16 Revision 3: Guidance on classification Rules for in vitro Diagnostic Medical Devices...
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe